Business
Purchase and Sale of Shares and PDMR Shareholdings
Purchase and Sale of Shares and PDMR Shareholdings.
About this update from Diaceutics Plc
[{"type":"text","content":"\n\n \n \n6 June 2023\n \nDiaceutics PLC\n(\"Diaceutics\" or \"the Company\")\n \nPurchase and Sale of Shares and PDMR Shareholdings\n \nDiaceutics PLC, (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical industry announces the following Director and PDMR share dealing.\n \nOn 5 June 2023, Nick Roberts, CFO of Diaceutics, purchased 21,742 ordinary shares of £0.002 each in the Company (\"Ordinary Shares\") at a price of 91.75 pence per Ordinary Share. As a result of the purchase, Nick's shareholding is 62,576 Ordinary Shares, representing approximately 0.07% of the Company's issued share capital.\n \n \nEnquiries:\n\n\n\n\n \nDiaceutics PLC \n\n\n\n\n\n\n\nPeter Keeling, Chief Executive Officer\nNick Roberts, Chief Financial Officer \n\n\nVia Alma PR \n\n\n\n\n\n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nomad & Broker)\n\n\nTel: +44 (0)20 7710 7600\n\n\n\n\nBen Maddison\n\n\n\n\n\n\n\nNick Harland\nNick Adams\nKate Hanshaw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAlma PR\n\n\nTel: +44(0)20 3405 0205\n\n\n\n\nCaroline Forde\n\n\[email protected]\n\n\n\n\nKieran Breheny\nMatthew Young\nKinvara Verdon\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nAbout Diaceutics\n \nAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enab...